DLPC increases insulin sensitivity, curbs fatty liver in mice

05/30/2011 | EndocrineWeb.com

Dilauroylphosphatidylcholine, a natural substance available in the form of lecithin supplements, appeared to improve insulin sensitivity and reduce the risks of fatty liver in tested mice, according to a study in the journal Nature. Experts said the findings may help improve these markers of type 2 diabetes in humans.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC